Wildcat Capital Management, LLC Gritstone Bio, Inc. Transaction History

Wildcat Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$7.07 - $11.61 $168,987 - $277,502	-23,902 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$8.45 - $12.28 $1.44 Million - $2.09 Million	-170,597 Reduced 87.71%	23,902 $206,000
Q1 2019 May 15, 2019	SELL	$9.97 - $18.96 $9 - $18	-1 Reduced -0.0%	194,499 $2.59 Million
Q3 2018 Nov 13, 2018	BUY	$14.24 - $14.24 $2.77 Million - $2.77 Million	194,500 New	194,500 $2.77 Million

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Wildcat Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wildcat Capital Management, LLC with notifications on news.